Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set

Achieving global elimination of hepatitis C virus requires a substantial scale‐up of testing. Point‐of‐care HCV viral load assays are available as an alternative to laboratory‐based assays to promote access in hard to reach or marginalized populations. The diagnostic performance and lower limit of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Jake R., Marsh, Elizabeth, Savinkina, Alexandra, Shilton, Sonjelle, Shadaker, Shaun, Tsertsvadze, Tengiz, Kamkamidze, George, Alkhazashvili, Maia, Morgan, Timothy, Belperio, Pam, Backus, Lisa, Doss, Waheed, Esmat, Gamal, Hassany, Mohamed, Elsharkawy, Aisha, Elakel, Wafaa, Mehrez, Mai, Foster, Graham R., Wose Kinge, Constance, Chew, Kara W., Chasela, Charles S., Sanne, Ian M., Thanung, Yin M., Loarec, Anne, Aslam, Khawar, Balkan, Suna, Easterbrook, Philippa J., Linas, Benjamin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248016/
https://www.ncbi.nlm.nih.gov/pubmed/35278339
http://dx.doi.org/10.1111/jvh.13672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248016/
https://www.ncbi.nlm.nih.gov/pubmed/35278339
http://dx.doi.org/10.1111/jvh.13672

Ejemplares similares